Diagnosis and management of hypertension in patients with Cushing's syndrome: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension
Year: 2022
Type: article
Abstract: Endogenous/exogenous Cushing's syndrome is characterized by a cluster of systemic manifestations of hypercortisolism, which cause increased cardiovascular risk. Its biological basis is glucocorticoid excess, acting on various pathogenic processes inducing cardiovascular damage. Hypertension is a common feature in Cushing's syndrome and may persist after normalizing hormone excess and discontinuing steroid therapy. In endogenous Cushing's syndrome, the earlier the diagnosis the sooner management can be employed to offset the deleterious effects of excess cortisol. Such management includes combined treatments directed against the underlying cause and tailored antihypertensive drugs aimed at controlling the consequences of glucocorticoid excess. Experts on endocrine hypertension and members of the Working Group on Endocrine Hypertension of the European Society of Hypertension (ESH) prepared this Consensus document, which summarizes the current knowledge in epidemiology, genetics, diagnosis, and treatment of hypertension in Cushing's syndrome.
Source: Journal of Hypertension
Authors: Francesco Fallo, Guido Di Dalmazi, Felix Beuschlein, Nienke R. Biermasz, Frederic Castinetti, Atanaska Elenkova, Martin Fassnacht, Andrea M. Isidori, Darko Kastelan, Márta Korbonits, John Newell-Price, Gianfranco Parati, Stephan Petersenn, Rosario Pivonello, Oskar Ragnarsson, Antoine Tabarin, Marily Theodoropoulou, Stylianos Tsagarakis, Elena Valassi, Przemysław Witek, Martin Reincke
Institutions: University of Padua, IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola, University of Bologna, University of Zurich, LMU Klinikum, University Hospital Zurich, Ludwig-Maximilians-Universität München, Leiden University Medical Center, Endo-ERN, Inserm, Aix-Marseille Université, Assistance Publique Hôpitaux de Marseille, Hôpital de la Conception, Centre de Génétique Médicale de Marseille, Medical University of Sofia, University Specialized Hospital for Active Treatment of Endocrinology, University of Würzburg, Universitätsklinikum Würzburg, Sapienza University of Rome, University Hospital Centre Zagreb, Queen Mary University of London, William Harvey Research Institute, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, University of Sheffield, IRCCS Istituto Auxologico Italiano, University of Milano-Bicocca, University of Duisburg-Essen, Federico II University Hospital, University of Naples Federico II, Sahlgrenska University Hospital, University of Gothenburg, Université de Bordeaux, Centre Hospitalier Universitaire de Bordeaux, Evangelismos Hospital, Hospital de Sant Pau, Hospital Universitari Germans Trias i Pujol, Medical University of Warsaw
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4291020319
